Home » Topics » BioWorld Science

BioWorld Science
RSS

Zhejiang University patents agents targeting ephrin-A1

April 30, 2019

Janssen initiates first-in-human study of JNJ-67856633

April 30, 2019

Bristol-Myers Squibb synthesizes new galectin 3 inhibitors

April 30, 2019

Ubiquitin carboxyl-terminal hydrolase 30 inhibitors discovered at FORMA Therapeutics

April 30, 2019

Patient enrollment begins in phase I study of CS1-CAR T therapy for multiple myeloma

April 30, 2019

Sidecar Therapeutics describes new MAP3K5 inhibitors

April 30, 2019

Biocad CJSC identifies EGFR Leu858Arg/Thr790Met double mutant inhibitors

April 30, 2019

LncRNA LINC01614 as a novel biomarker of poor survival in HNSCC

April 30, 2019

Momenta Pharmaceuticals presents best-in-class anti-CD38 therapeutic

April 30, 2019

Potential Hep B immunotherapeutic target identified

April 30, 2019

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...